Philips and SURFsara Team up to Provide Hospitals with 'Big Data' Research Services in the Cloud for Precision Medicine and Population Health Management

PhilipsRoyal Philips (NYSE: PHG; AEX: PHIA) and SURFsara (a subsidiary of the SURF cooperation), the leading Dutch high-performance supercomputing and data infrastructure provider for education and academic research, today announced a new collaboration with the aim to connect the Philips HealthSuite cloud platform to the SURFsara National Research Infrastructure to provide new cloud-based research services.

The services will specifically support research into precision medicine and population health. An example are new targeted therapies for colon, prostate or breast cancer that require bringing together massive amounts of data from medical scanners, tissue biopsies, lab results and genomics over long periods of time to generate deep and comprehensive views on a patient’s individual situation. Studies into population health need to combine extremely large health data sets of large groups of people. These are analyzed to find even the smallest correlations and patterns that could eventually lead to new approaches to enable early intervention and improve treatments

"Today, hospitals can already retrieve massive amounts data from multiple sources and various disciplines, and through research obtain new clinical insights," said Jeroen Tas, CEO Connected Care and Health Informatics at Philips. "But even greater value lies in combining, normalizing and analyzing the current islands of data. Our integrated services aim to combine data on all levels and connect health systems, clinical expertise and research programs in a secure and compliant manner. Through networked healthcare research we want to facilitate collaboration on the next generation of breakthroughs in care delivery."

Via a user-friendly portal for online collaboration, data scientists and clinical researchers will have secure high-speed access to Big Data, supercomputing facilities, combined Philips and SURFsara analytics tools, machine learning technology and IT services. It aims to enable scientists and researchers to seamlessly move, share, combine and re-use extremely large sets of data available across academic medical institutions and research programs and analyze them in a compliant manner.

"SURFsara supports the national life science research with ICT experience and has a mission to connect business to research," said Anwar Osseyran, SURFsara CEO and Professor of Business Analytics and Computer Science at the University of Amsterdam. "We will collaborate with Philips to enhance the cloud-base services of Philips and use these resources to make life science data available for science in the Netherlands and beyond."

The comprehensive new translational research environment envisaged initially aims to facilitate academic medical institutions and research programs, and will later expand to support healthcare centers of excellence and life sciences scholars to analyze the vast amounts of data generated by disciplines such as genomics, digital pathology and imaging. The Big Data research services will be open to collaborative research initiatives throughout Europe and beyond, reflecting the global nature of modern-day connected healthcare research in a compliant manner.

The volume of stored clinical data is growing at around 40% per year due to rapid advancements in diagnostic medical imaging and patient monitoring, chronic disease management as well as the growing adoption of medical-grade IoT devices (unobtrusive sensors) that enable enhanced patient self-measurement and opens a new dimension in high quality data collection. An even greater data explosion is predicted as access to and analysis of digital pathology and genomics data becomes more widely adopted.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries.

About URFsara
SURFsara has the national high performance infrastructure for academic research, medical centers and research institutions. We create the bridge between research and our advanced ICT. We do so with scientific research in our DNA and unique expertise contained in our large scale infrastructure. This enables us to boost scientific research with complex computational modeling and analytics and management of big data. We also focus on developing initiatives for the business community.

SURFmarket, SURFnet and SURFsara are subsidiaries of the SURF cooperation, the collaborative ICT organization for Dutch education and research. SURF offers students, lecturers and scientists in the Netherlands access to the best possible internet and ICT facilities.

Most Popular Now

Artificial Intelligence Solution Improve…

Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that difficulty finding the right volunteer subjects can undermine the effectiveness of...

South West London Pathology Picks CliniS…

One of the first pathology networks in the country, set up to serve more than two million people in south west London, has signed a contract with CliniSys for a...

Call for Tenders: Studies on eHealth, In…

The European Commission is launching a tender for two studies to survey and analyse progress on the digital transformation of the health and care in the EU, in particular with...

AI-based AI-Rad Companion Chest CT Softw…

AI-Rad Companion Chest CT(1), an intelligent software assistant for radiology, was recently awarded the CE mark, which means Siemens Healthineers can start marketing this artificial intelligence (AI)-based software as a...

Spot On for Healthcare Technology Startu…

10 - 12 October 2019, Berlin, Germany. XPOMET Medicinale brings together care providers, patients, and in general stakeholders from all health-related fields and geographic regions. The Festival of Future Medicine and...

Isansys Named as Finalist for OBN's Most…

Isansys Lifecare is proud to announce it has been shortlisted in the Most Transformative Digital Healthcare Company category at the OBN Annual Awards 2019. The award recognises the significant uptake...

7th MEDICA MEDICINE + SPORTS CONFERENCE

18 - 21 November 2019, Düsseldorf, Germany. What lengths do top athletes go to in order to reach peak performances and which findings in the field of professional sports are relevant...

How can We Successfully Converge the Hea…

Opinion Article by Erik Janssen, VP, Innovative Solutions, Neurology, UCB Pharma. The fourth industrial revolution is upon us and fundamentally changing the way we live, work and interact across all industries...

Carestream Health Completes Sale of Heal…

Carestream Healthhas completed the sale of the company's healthcare information solutions business to Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, in 26 of the 38...

Allscripts Listed on Lot One of Health S…

Allscripts has been included on a new list of accredited suppliers of electronic patient records that has been published by NHS England and NHSX. The company is one of just...